Medtronic Cardiac Ablation Solutions

This study is observing how well a specific heart ablation device works over three years for people with persistent atrial fibrillation that hasn't responded to medication. About 200 participants will have the ablation procedure and be followed to see if their irregular heart rhy…

This study is testing a new medical device system for treating a type of irregular heartbeat called paroxysmal atrial fibrillation (PAF). The system uses a special catheter to map the heart and deliver targeted energy to areas causing the problem. Researchers will enroll up to 30…

This study follows 200 patients with recurrent atrial fibrillation symptoms to see how well a freezing catheter procedure works over three years. The procedure freezes small areas of heart tissue to prevent irregular heartbeats, offering an alternative to medication. Researchers …

This study is testing a new medical device called the SpherePVI™ catheter system for treating paroxysmal atrial fibrillation, a type of irregular heartbeat. The trial will enroll 100 participants who haven't responded well to medication to see if the device can safely and effecti…

This study is testing a new medical device called the SpherePVI™ Multi-Ablation System to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. The device uses a catheter to deliver targeted energy to isolate problematic veins in the heart that cause the irregular …

This study is tracking patients for three years after they receive a specific heart procedure called the PulseSelect PFA System to treat atrial fibrillation. The goal is to see how many patients stay free from irregular heart rhythms and to monitor for any safety issues related t…

This study is testing a new medical device system to treat a dangerous, fast heart rhythm called ventricular tachycardia (VT). The procedure uses a special catheter to deliver energy to scarred heart tissue to stop the abnormal rhythm. Researchers want to see if this new system i…

This study is collecting real-world information on how well a new heart procedure device works and how safe it is for people with atrial fibrillation (an irregular heartbeat). It will follow about 1,950 patients who receive the PulseSelect PFA treatment in hospitals around the wo…

This study is collecting real-world data on how well the Affera cardiac ablation system works for treating atrial fibrillation (irregular heartbeat). Researchers will follow 540 patients worldwide who receive this already-approved treatment to track how many stay free from irregu…

This study is a registry that will collect real-world information on how well a specific heart ablation system works and how safe it is. It will follow 1,000 adult patients with irregular heartbeats (arrhythmias) for at least one year after their procedure. The goal is to underst…